Hemispherx Biopharma Extends Its Strategic Alliance With Armada Health Care for Alferon N Injection(R)
August 17, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx"), announced that as the Company works toward the re-launch of Alferon N, it has...